PsyAccess
Spravato®Registry-verifiedDesignated-centers model

Szpital Wojewódzki Im. Prymasa Kardynała Stefana Wyszyńskiego W Sieradzu

Warta, Poland

Treatment & access

About this provider

The Psychiatric Center in Warta is part of the Cardinal Stefan Wyszyński Provincial Hospital in Sieradz. Its Observation-Diagnostic Ward 3 specializes in treatment-resistant mental disorders and explicitly offers intranasal esketamine under NFZ drug program B.147, alongside intravenous racemic ketamine infusions, electroconvulsive therapy and lithium augmentation. The ward team includes psychiatrists, psychologists, a sexologist and a social worker, with EEG, ECG and imaging diagnostics available; per NFZ data there was no waiting queue for the program as of mid-2026.

Services & programs

  • Observation-diagnostic psychiatric wards for adults, including diagnosis and therapy of treatment-resistant depression and severe psychoses
  • Intranasal esketamine under NFZ drug program B.147
  • Intravenous racemic ketamine infusions
  • Electroconvulsive therapy (ECT)
  • Lithium augmentation of treatment
  • Mental health outpatient clinic and Mental Health Center in Warta
  • EEG, ECG and imaging diagnostics

Common questions

Where exactly is the esketamine program run — in Sieradz or in Warta?

At the Psychiatric Center in Warta (ul. Sieradzka 3, Warta), which is an organizational part of the Provincial Hospital in Sieradz. Observation-Diagnostic Ward 3 lists intranasal esketamine under program B.147 among its treatment options.

What do I need to qualify for program B.147 here?

You must be 18-75 with a current moderate-to-severe depressive episode that has not responded to at least two antidepressants used adequately. Qualification is done by the center's psychiatrists; bring your referral and prior treatment documentation. Treatment under the program is fully NFZ-funded for up to 34 weeks.

What if esketamine is not suitable for me?

This ward is unusual in offering several options for treatment-resistant depression at one site — IV racemic ketamine infusions, electroconvulsive therapy and lithium augmentation — so the team can propose an alternative pathway after assessment.

Looking at alternatives? One of the NFZ program B.147 centers — see all program centers in Poland in the directory and the Poland access guide.

Verification

This record was taken directly from an official registry or program list and is re-checked on a rolling cadence.

Spotted an error? See our methodology for how records are checked and how to report a correction.